After treatment, low-differentiated cervical cancer can obtain a five-year survival rate of about 5% to 80%, which should be analyzed with the stage of the disease. Cervical cancer is a common malignant tumor in women, and the occurrence of the disease is related to a variety of factors such as heredity and human papillomavirus infection. Low differentiation represents higher malignancy and poorer prognosis. After diagnosis, the disease can be treated by surgery, radiotherapy, chemotherapy and other methods, and the specific prognosis is more related to the stage. After active treatment, stage I cervical cancer can obtain a five-year survival rate of about 80%; stage II to III is about 30% to 60%; stage IV is between 5% and 10%. Generally speaking, the earlier the stage, the better the prognosis, and after the operation, attention should be paid to follow the doctor’s instructions for regular review to minimize the recurrence.